Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC – Get Free Report) was the target of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 14,573 shares, an increase of 211.9% from the July 30th total of 4,673 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 4,750 shares, the days-to-cover ratio is currently 3.1 days.
Cardiac Biotech Solutions Stock Performance
OTCMKTS:CBSC opened at $0.04 on Thursday. Cardiac Biotech Solutions has a one year low of $0.02 and a one year high of $0.06. The firm’s 50 day simple moving average is $0.03 and its 200 day simple moving average is $0.04.
About Cardiac Biotech Solutions
CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.
Featured Stories
- Five stocks we like better than Cardiac Biotech Solutions
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
